BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2552305)

  • 1. Production of inositol-phospholipid-derived second messengers in a rat natural killer cell line exposed to susceptible tumor targets.
    Atkinson EA; Gerrard JM; Hildes GE; Greenberg AH
    Nat Immun Cell Growth Regul; 1989; 8(4):223-30. PubMed ID: 2552305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the mechanism of natural killer (NK) degranulation and cytotoxicity.
    Atkinson EA; Gerrard JM; Hildes GE; Greenberg AH
    J Leukoc Biol; 1990 Jan; 47(1):39-48. PubMed ID: 2152939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP.
    Windebank KP; Abraham RT; Powis G; Olsen RA; Barna TJ; Leibson PJ
    J Immunol; 1988 Dec; 141(11):3951-7. PubMed ID: 2846696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.
    Ryan JC; Niemi EC; Goldfien RD; Hiserodt JC; Seaman WE
    J Immunol; 1991 Nov; 147(9):3244-50. PubMed ID: 1919012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS; Schoon RA; Leibson PJ
    J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocytic differentiation of HL60 human promyelocytic leukemia cells is preceded by a reduction in levels of inositol lipid-derived second messengers.
    Porfiri E; Hoffbrand AV; Wickremasinghe RG
    Exp Hematol; 1988 Aug; 16(7):641-6. PubMed ID: 2839354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A central role for phosphoinositide hydrolysis in activating the lytic mechanism of human natural killer cells.
    Chow SC; Jondal M
    Immunology; 1990 May; 70(1):106-10. PubMed ID: 2162323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
    Roozemond RC; van der Geer P; Bonavida B
    J Immunol; 1986 May; 136(10):3921-9. PubMed ID: 3701064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of gene expression by the intracellular second messengers IP3 and diacylglycerol.
    Kimmel AR; Eisen M
    Dev Genet; 1988; 9(4-5):351-8. PubMed ID: 3266590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
    Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR
    J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of inositol cycle in large granular lymphocyte leukemia RNK following contact with an NK-sensitive tumor.
    Gerrard JM; Hildes E; Atkinson EA; Greenberg AH
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():573-6. PubMed ID: 2821768
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
    J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
    Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
    J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45-negative mutants of a rat natural killer cell line fail to lyse tumor target cells.
    Bell GM; Dethloff GM; Imboden JB
    J Immunol; 1993 Oct; 151(7):3646-53. PubMed ID: 8104222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat.
    Reynolds CW; Bere EW; Ward JM
    J Immunol; 1984 Jan; 132(1):534-40. PubMed ID: 6197459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect on inositol-phospholipid hydrolysis, cytosolic-free Ca2+ concentration, protein kinase C activity and protein phosphorylation of 1-oleoyl-2-acetyl-sn-glycerol growth-stimulated ascites tumor cells.
    Seibicke S; Strosznajder JB; Haeffner EW
    Eur J Cell Biol; 1988 Aug; 46(3):403-10. PubMed ID: 2846301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.